Skip to main content
The recent federal approval of nonprescription sales of the emergency contraceptive Plan B (Barr Laboratories; Woodcliffe Lake, NJ) to women and men ages 18 and older may have quieted what was a brewing controversy in emergency medicine. However, the ethical issues that gave rise to the debate still are very much in play, emergency department (ED) experts say.

Nonprescription sales of Plan B still murky waters